Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1189 | 8869 | 30.5 | 53% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
278 | 38614 | DELIRIUM//BENZODIAZEPINES//PERIPHERAL BENZODIAZEPINE RECEPTORS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1837 | 2393 | BRETAZENIL//ABECARNIL//FLUMAZENIL |
3617 | 1869 | BENZODIAZEPINES//BENZODIAZEPINE DEPENDENCE//BENZODIAZEPINE USE |
4588 | 1688 | ZOLPIDEM//ZOPICLONE//ZALEPLON |
7833 | 1245 | 7 AMINOFLUNITRAZEPAM//BROMAZEPAM//FLUNITRAZEPAM |
12440 | 842 | LORAZEPAM//BROMAZEPAM//M EAMENTO CEREBRAL INTEGRACAO SENSORIO MOT |
23674 | 283 | N DESMETHYLADINAZOLAM//CHLORDESMETHYLDIAZEPAM//ADINAZOLAM |
24504 | 259 | BENZODIAZEPINOOXAZOLE//DAYA DRUG DISCOVERIES INC//PHARM NAKA KU |
28397 | 169 | ALKOXYCOUMARIN DEALKYLASE//PHENAZEPAM//GIDAZEPAM |
31572 | 121 | I 125 IOMAZENIL//ACQUISITION OF OPERANT BEHAVIOR//ACTIVE SHUTTLEBOX AVOIDANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BENZODIAZEPINES | Author keyword | 245 | 29% | 8% | 726 |
2 | ZOLPIDEM | Author keyword | 205 | 51% | 3% | 292 |
3 | ZOPICLONE | Author keyword | 131 | 63% | 1% | 133 |
4 | BENZODIAZEPINE | Author keyword | 81 | 20% | 4% | 357 |
5 | TRIAZOLAM | Author keyword | 67 | 44% | 1% | 116 |
6 | BROMAZEPAM | Author keyword | 53 | 69% | 1% | 45 |
7 | ZALEPLON | Author keyword | 46 | 58% | 1% | 53 |
8 | HYPNOTICS | Author keyword | 45 | 30% | 1% | 126 |
9 | LORAZEPAM | Author keyword | 41 | 27% | 1% | 133 |
10 | FLUNITRAZEPAM | Author keyword | 40 | 36% | 1% | 91 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BENZODIAZEPINES | 245 | 29% | 8% | 726 | Search BENZODIAZEPINES | Search BENZODIAZEPINES |
2 | ZOLPIDEM | 205 | 51% | 3% | 292 | Search ZOLPIDEM | Search ZOLPIDEM |
3 | ZOPICLONE | 131 | 63% | 1% | 133 | Search ZOPICLONE | Search ZOPICLONE |
4 | BENZODIAZEPINE | 81 | 20% | 4% | 357 | Search BENZODIAZEPINE | Search BENZODIAZEPINE |
5 | TRIAZOLAM | 67 | 44% | 1% | 116 | Search TRIAZOLAM | Search TRIAZOLAM |
6 | BROMAZEPAM | 53 | 69% | 1% | 45 | Search BROMAZEPAM | Search BROMAZEPAM |
7 | ZALEPLON | 46 | 58% | 1% | 53 | Search ZALEPLON | Search ZALEPLON |
8 | HYPNOTICS | 45 | 30% | 1% | 126 | Search HYPNOTICS | Search HYPNOTICS |
9 | LORAZEPAM | 41 | 27% | 1% | 133 | Search LORAZEPAM | Search LORAZEPAM |
10 | FLUNITRAZEPAM | 40 | 36% | 1% | 91 | Search FLUNITRAZEPAM | Search FLUNITRAZEPAM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BENZODIAZEPINES | 166 | 25% | 6% | 571 |
2 | TRIAZOLAM | 152 | 44% | 3% | 266 |
3 | DIAZEPAM | 129 | 18% | 7% | 657 |
4 | REBOUND INSOMNIA | 97 | 68% | 1% | 85 |
5 | HYPNOTICS | 81 | 48% | 1% | 122 |
6 | ZOPICLONE | 79 | 51% | 1% | 112 |
7 | ZOLPIDEM | 68 | 31% | 2% | 180 |
8 | 1 4 BENZODIAZEPINES | 56 | 47% | 1% | 87 |
9 | TERM THERAPEUTIC USE | 49 | 63% | 1% | 50 |
10 | RO 15 1788 | 47 | 35% | 1% | 110 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOPSYCHIATRIA | 2 | 14% | 0% | 16 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal | 2013 | 28 | 123 | 53% |
Withdrawing Benzodiazepines in Primary Care | 2009 | 59 | 81 | 89% |
Benzodiazepine harm: how can it be reduced? | 2014 | 12 | 30 | 67% |
Meta-analysis of benzodiazepine use in the treatment of insomnia | 2000 | 205 | 90 | 68% |
CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM - THERAPEUTIC IMPLICATIONS | 1995 | 168 | 19 | 95% |
Zolpidem - An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia | 2000 | 151 | 121 | 81% |
BENZODIAZEPINES - USE, ABUSE, AND CONSEQUENCES | 1992 | 417 | 570 | 56% |
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data | 2003 | 128 | 53 | 83% |
Zolpidem - A review of its use in the management of insomnia | 2005 | 104 | 75 | 79% |
Is there really a link between benzodiazepine use and the risk of dementia? | 2015 | 1 | 34 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP ADDICT BEHAV | 4 | 67% | 0.0% | 4 |
2 | FYSIOL BIOCHEM BIOMETRIE | 4 | 75% | 0.0% | 3 |
3 | HEYMANS PHARMACOL PHARMACOTHER Y | 4 | 75% | 0.0% | 3 |
4 | PHARM CLIN PHARMACOL GERIATR PHARMACOTHER | 4 | 75% | 0.0% | 3 |
5 | STATE FORENS MED SERV | 4 | 75% | 0.0% | 3 |
6 | M EAMENTO CEREBRAL INTEGRACAO SENSORIO MOT | 4 | 36% | 0.1% | 8 |
7 | CELLULAR MOL NEUROBIOL PROGRAM | 3 | 50% | 0.1% | 5 |
8 | DAYA DRUG DISCOVERIES INC | 3 | 100% | 0.0% | 3 |
9 | PHARM NAKA KU | 3 | 50% | 0.0% | 4 |
10 | CIENCIAS QUIM ANALIT DO 644 | 3 | 60% | 0.0% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000025567 | PERIPHERAL BENZODIAZEPINE RECEPTORS//TSPO//DIAZEPAM BINDING INHIBITOR |
2 | 0.0000022770 | GLYCINE RECEPTOR//GABAA RECEPTOR//HYPEREKPLEXIA |
3 | 0.0000011227 | ALCOHOL WITHDRAWAL//DELIRIUM TREMENS//ALCOHOL WITHDRAWAL SYNDROME |
4 | 0.0000011050 | MDMA//ECSTASY//3 4 METHYLENEDIOXYMETHAMPHETAMINE |
5 | 0.0000010831 | ULTRASONIC VOCALIZATION//PLAY FIGHTING//ISOLATION REARING |
6 | 0.0000009856 | DRUG INDUCED DEPRESSION//BUZEPIDE METHIODIDE//DEPRESSIVE DISORDER CHEMICALLY INDUCED |
7 | 0.0000009743 | INSOMNIA//SLEEP//SLEEP DURATION |
8 | 0.0000009684 | NONMEDICAL USE//PRESCRIPTION DRUG ABUSE//PRESCRIPTION OPIOIDS |
9 | 0.0000006945 | GAMMA HYDROXYBUTYRIC ACID//GHB//GAMMA HYDROXYBUTYRIC ACID GHB |
10 | 0.0000006755 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |